Inventor
HARIKRISHNAN LALGUDI S
US19 patents
⚠️ This page may combine multiple inventors who share the name “HARIKRISHNAN LALGUDI S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS7001911B2Feb 21, 2006
Fused cyclic modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO31 citations91
US7888376B2Feb 15, 2011
Heterocyclic CETP inhibitors
BRISTOL MYERS SQUIBB CO8 citations84
US7790770B2Sep 7, 2010
Heterocyclic CETP inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US10053454B2Aug 21, 2018
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US11660311B2May 30, 2023
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO2 citations71
US12012374B2Jun 18, 2024
Agonists of ROR GAMMAt
BRISTOL MYERS SQUIBB CO0 citations62
US11667663B2Jun 6, 2023
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations61
US7432267B2Oct 7, 2008
Fused cyclic modulators of nuclear hormone receptor function
BRISTOL MYERS SQUIBB CO2 citations61
US11339185B2May 24, 2022
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations60
US10336761B2Jul 2, 2019
TGFβ receptor antagonist
BRISTOL MYERS SQUIBB CO1 citations60
US10292985B2May 21, 2019
TGF beta receptor antagonists
BRISTOL MYERS SQUIBB CO1 citations58
US10196387B2Feb 5, 2019
Carbazole compounds useful as bromodomain inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US10519187B2Dec 31, 2019
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations50
US10683290B2Jun 16, 2020
Tricyclic compounds as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations41
US10744150B2Aug 18, 2020
Cyclic dinucleotides as anticancer agents
BRISTOL MYERS SQUIBB CO0 citations40
US10399987B2Sep 3, 2019
TGF beta receptor antagonists
BRISTOL MYERS SQUIBB CO0 citations37